Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Neurology|June 23, 2012
GBA-associated PD. Neurodegeneration, altered membrane metabolism, and lack of energy failureKathrin Brockmann, Ruediger Hilker, Ulrich Pilatus, et al.European Journal of Neurology|January 15, 2021
The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s diseaseMilan Zimmermann, Leonie Köhler, Marketa Kovarova, et al.NPJ Parkinson'S Disease|December 1, 2025
Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson's diseaseKathrin Brockmann, Alice Ticca, Stefanie Lerche, et al.Movement Disorders : Official Journal of the Movement Disorder Society|August 23, 2018
Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's diseaseStefanie Lerche, Inga Liepelt-Scarfone, Isabel Wurster, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 28, 2021
CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLBStefanie Lerche, Simon Sjödin, Ann Brinkmalm, et al.NPJ Parkinson'S Disease|September 15, 2022
Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seedingIsabel Wurster, Corinne Quadalti, Marcello Rossi, et al.Plos One|September 24, 2013
Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot studyMichelle M Mielke, Walter Maetzler, Norman J Haughey, et al.BMC Neurology|March 29, 2022
Genotype-Phenotype correlations of SCARB2 associated clinical presentation: a case report and in-depth literature reviewBurcu Atasu, Ayse Nur Ozdag Acarlı, Basar Bilgic, et al.NPJ Parkinson'S Disease|January 19, 2024
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson's diseaseKathrin Brockmann, Stefanie Lerche, Simone Baiardi, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 2019
Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha-Synuclein ProfilesStefanie Lerche, Isabel Wurster, Benjamin Roeben, et al.Pageof 4